Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Parkinson's Disease
Levodopa
gene therapy
Voyager Therapeutics
Bayer
AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial
Pharmaforum
Sat, 10/30/21 - 10:48 pm
AbbVie
ABV-951
Parkinson's Disease
clinical trials
Positive Results in Hand, AbbVie Eyes Potential Approval for Parkinson’s Treatment
BioSpace
Thu, 10/28/21 - 10:16 pm
AbbVie
Parkinson's Disease
ABBV-951
clinical trials
Why Supernus' Acquisition of Adamas Is a Smart Move
Motley Fool
Thu, 10/21/21 - 09:30 am
Supernus
Adamas Pharmaceuticals
M&A
Parkinson's Disease
Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson's
Fierce Biotech
Wed, 10/20/21 - 10:23 am
Chase Therapeutics
CTC-501
CTC-413
clinical trials
major depression
Parkinson's Disease
Supernus expands its portfolio of Parkinson's drugs with a $400M+ buyout
Endpoints
Mon, 10/11/21 - 10:08 am
Supernus
Parkinson's Disease
M&A
Adamas Pharmaceuticals
Oncotelic Hopes to Leverage Intranasal Apomorphine to Treat Parkinson’s Disease
BioSpace
Mon, 10/4/21 - 10:57 pm
Oncotelic
immuno-oncology
RNA
small molecule drugs
Parkinson's Disease
erectile dysfunction
Neuro startup Vanqua Bio emerges with $85M and a first focus on Parkinson’s
MedCity News
Wed, 09/15/21 - 10:39 am
Vanqua Bio
Parkinson's Disease
funding
Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson's
BioSpace
Tue, 08/24/21 - 11:12 am
Roche
Shape Therapeutics
RNA editing
RNAfix
Alzheimer's disease
Parkinson's Disease
Athira Looks to Advance Alzheimer’s, Parkinson’s Disease Research Amid CEO Debacle
BioSpace
Wed, 08/18/21 - 11:01 am
Athira Pharma
CEO
Alzheimer's disease
Parkinson's Disease
R&D
AbbVie, on a Mission, picks Alzheimer's, Parkinson's targets, as partner nabs $20M
Fierce Biotech
Mon, 08/9/21 - 11:05 am
AbbVie
Mission Therapeutics
Parkinson's Disease
Alzheimer's disease
Study: Drug Candidate Improves Brain Energy Metabolism in Parkinson’s, MS
BioSpace
Thu, 08/5/21 - 11:19 pm
Clene
Parkinson's Disease
MS
clinical trials
AC Immune acquires Parkinson’s vaccine candidate
Biopharma Reporter
Tue, 07/27/21 - 04:25 pm
AC Immune
Affris
vaccines
Parkinson's Disease
FDA gives speedy review to Bayer’s Parkinson’s stem cell therapy
Pharmaforum
Tue, 07/20/21 - 11:14 am
Bayer
BlueRock Therapeutics
FDA
DA01
stem cells
Parkinson's Disease
Four New Biotechs Launch to Combat MD, NASH, Parkinson's and More
BioSpace
Wed, 06/23/21 - 10:44 pm
funding
Vita Therapeutics
limb-girdle muscular dystrophy
NuvoAir
Respiratory
Enveda Biosciences
NASH
Parkinson's Disease
ImmuneID
immunology
FDA Rejects Verily’s Smartwatch for Parkinson’s Assessment
Parkinson's News Today
Mon, 06/14/21 - 10:34 am
Verily
FDA
smartwatch
Parkinson's Disease
devices
AbbVie snags another preclinical Parkinson's program with $17M Caraway pact
Fierce Pharma
Wed, 06/9/21 - 10:45 pm
AbbVie
Caraway Therapeutics
Parkinson's Disease
Bayer's billon-dollar Parkinson's disease bets land in the clinic
Fierce Biotech
Tue, 06/8/21 - 11:15 am
Bayer
Parkinson's Disease
DA01
BlueRock Therapeutics
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
BioSpace
Tue, 04/13/21 - 10:17 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Bain Capital
Novaquest
A busy year ahead for Parkinson’s disease
EP Vantage
Wed, 03/3/21 - 10:56 am
Parkinson's Disease
drug development
AstraZeneca
Roche
Prothena
MeiraGTx
Annovis Bio
Sanofi
Alkahest
Peptron
SAGE Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »